High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model

Ellmerich, S., Mycko, M., Takacs, K., Waldner, H., Wahid, F. N., Boyton, R. J., King, R. H. M., Smith, P. A., Amor, S., Herlihy, A. H., Hewitt, R. E., Jutton, M., Price, David ORCID: https://orcid.org/0000-0001-9416-2737, Hafler, D. A., Kuchroo, V. K. and Altmann, D. M. 2005. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. The Journal of Immunology 174 (4) , pp. 1938-1946. 10.4049/jimmunol.174.4.1938

Full text not available from this repository.

Abstract

Multiple sclerosis (MS) is thought to involve CD4 T cell recognition of self myelin, many studies focusing on a pathogenic role for anti-myelin, HLA-DR15-restricted T cells. In experimental allergic encephalomyelitis, it is known which epitopes trigger disease and that disease is associated with determinant spread of T cell reactivity. Characterization of these events in human MS is critical for the development of peptide immunotherapies, but it has been difficult to define the role of determinant spread or define which epitopes might be involved. In this study, we report humanized transgenic mice, strongly expressing HLA-DR15 with an MS-derived TCR; even on a RAG-2 wild-type background, mice spontaneously develop paralysis. Disease, involving demyelination and axonal degeneration, correlates with inter- and intramolecular spread of the T cell response to HLA-DR15-restricted epitopes of myelin basic protein, myelin oligodendrocyte glycoprotein, and αB-crystallin. Spread is reproducible and progressive, with two of the epitopes commonly described in responses of HLA-DR15 patients. The fact that this pattern is reiterated as a consequence of CNS tissue damage in mice demonstrates the value of the transgenic model in supplying an in vivo disease context for the human responses. This model, encompassing pathologically relevant, spontaneous disease with the presentation of myelin epitopes in the context of HLA-DR15, should offer new insights and predictions about T cell responses during MS as well as a more stringent test bed for immunotherapies.

Item Type:	Article
Status:	Published
Schools:	Medicine
Publisher:	American Association of Immunologists
ISSN:	0022-1767
Date of First Compliant Deposit:	5 May 2016
Date of Acceptance:	11 November 2004
Last Modified:	01 Nov 2022 10:09
URI:	https://orca.cardiff.ac.uk/id/eprint/90451

Citation Data

Cited 64 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item